LivaNova (FRA:LIA) Other Current Payables: €0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LIA LivaNova PLC FRA:LIA
74 GF Score
Price €71.00
GF Value €53.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Other Current Payables?

LivaNova FRA:LIA -0.70% 74 Other Current Payables is €0 Mil as of Mar. 2026. GuruFocus rates FRA:LIA with a GF Score™ of 74/100 and a GF Value™ of €53.56 (Significantly Overvalued). The stock has 7 warning signs investors should review.

LivaNova's Other Current Payables for the quarter that ended in Mar. 2026 was €0 Mil.

LivaNova's quarterly Other Current Payables declined from Sep. 2025 (€0 Mil) to Dec. 2025 (€0 Mil) but then stayed the same from Dec. 2025 (€0 Mil) to Mar. 2026 (€0 Mil).

LivaNova's annual Other Current Payables increased from Dec. 2023 (€-0 Mil) to Dec. 2024 (€0 Mil) but then declined from Dec. 2024 (€0 Mil) to Dec. 2025 (€0 Mil).

LivaNova Other Current Payables Related Terms

LivaNova Other Current Payables Historical Data

* Premium members only.

The historical data trend for LivaNova's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Other Current Payables Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.11 -0.00 -0.00 0.00 0.00

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:LIA
74GF Score
LivaNova PLC FRA:LIA
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0 Mil mean?
LivaNova (FRA:LIA) has a Other Current Payables of €0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on LivaNova and its competitors.
Is LivaNova's Other Current Payables too high?
LivaNova's current Other Current Payables is €0 Mil. Overall, LivaNova has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Other Current Payables compare to IRTC and HAE?
LivaNova's Other Current Payables of €0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on LivaNova and its competitors. LivaNova's current Other Current Payables is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (FRA:LIA) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.56, compared to a current price of €71.00 — trading 32.6% above its estimated fair value. The current Other Current Payables is €0 Mil. LivaNova's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For LivaNova (FRA:LIA), the current Other Current Payables is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (FRA:LIA) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of €71.00 is trading 32.6% above its estimated GF Value™ of €53.56. GuruFocus considers LivaNova to be Significantly Overvalued.

Key valuation signals for FRA:LIA:

  • Other Current Payables: €0 Mil
  • GF Value™: €53.56 vs. price of €71.00 (32.6% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the FRA:LIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIVN:USA
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
74GF Score

Get the complete analysis for FRA:LIA

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.00
Price
€53.56
GF Value